The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 3 randomized study of loncastuximab tesirine in combination with rituximab (Lonca-R) versus immunochemotherapy in patients with R/R DLBCL (LOTIS-5).
 
Mehdi Hamadani
Honoraria - Celgene
Consulting or Advisory Role - ADC Therapeutics; Gamida Cell; Genmab; Incyte; Kite/Gilead; MorphoSys; Novartis; Omeros; Puma Biotechnology (I); Seagen; Verastem
Speakers' Bureau - ADC Therapeutics; AstraZeneca; BeiGene; Genzyme; Kite/Gilead
Research Funding - Astellas Pharma; Genzyme; Genzyme; Otsuka; Spectrum Pharmaceuticals; Takeda
 
Yuliya Linhares
Consulting or Advisory Role - ADC Therapeutics; AstraZeneca/Merck; BeiGene; Genentech; Gilead Sciences; GlaxoSmithKline; Kyowa Kirin International; Seagen
Speakers' Bureau - Kyowa Kirin International
Research Funding - BeiGene
 
Mitul Gandhi
Honoraria - GlaxoSmithKline; Janssen Oncology (Inst); Karyopharm Therapeutics; TG Therapeutics
 
Michael Chung
Stock and Other Ownership Interests - The Oncology Institute of Hope and Innovation
Research Funding - The Oncology Institute of Hope and Innovation
 
Helena Adamis
Employment - ADC Therapeutics
Stock and Other Ownership Interests - ADC Therapeutics
Research Funding - ADC Therapeutics (Inst)
 
David Ungar
Employment - ADC Therapeutics
Stock and Other Ownership Interests - ADC Therapeutics
 
Carmelo Carlo-Stella
Honoraria - AstraZeneca; Bristol-Myers Squibb; Celgene/Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; Incyte; Janssen Oncology; Merck Sharp & Dohme; Novartis
Consulting or Advisory Role - ADC Therapeutics; Celgene/Bristol-Myers Squibb; Karyopharm Therapeutics; Novartis; Roche; Sanofi
Research Funding - ADC Therapeutics (Inst); Roche (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - ADC Therapeutics; Janssen; Roche; Takeda
 
Ed Kingsley
Employment - US Oncology
Research Funding - ADC Therapeutics; BeiGene; Daiichi Sankyo
 
Julien Depaus
Consulting or Advisory Role - Novartis
Travel, Accommodations, Expenses - AstraZeneca Spain
 
Sylvia Snauwaert
Consulting or Advisory Role - Abbvie
 
Michal Kwiatek
Speakers' Bureau - Abbvie
Research Funding - ADC Therapeutics; Janssen; Menarini
 
Javier López-Jiménez
Consulting or Advisory Role - Abbvie; Gilead Sciences; Janssen Oncology; Roche/Genentech
Speakers' Bureau - Abbvie; Pfizer; Roche/Genentech
Research Funding - Abbvie; Roche/Genentech
Travel, Accommodations, Expenses - Abbvie; Gilead Sciences; Janssen Oncology